Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
23 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Companies
Top Ten Companies //
Browse A - Z of companies
Merck KGaA
(Merck)
Merck
(Merck KGaA)
Pfizer
Roche
Novartis
GlaxoSmithKline
(GSK)
GSK
(GlaxoSmithKline)
Bristol-Myers Squibb
Lilly
Bayer
Browse the A - Z of Companies
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
C&O Pharma
Cadence Pharmaceuticals
Cadila Pharmaceuticals
Cadisa
Caisson Biotech
Caliber Biotherapeutics
California Stem Cell
Calistoga Pharmaceuticals
Callisto Pharmaceuticals
Calypso Biotech
Cambrex Corp
Cambridge Major Laboratories
Camurus
Canabis Science
Cancer Research Technology
Cancer Therapeutics CRC
Canderm Pharma
Cangene
Cangene Corp
Cangenix
Cannabis Science
Capsant Neurotechnologies
Capsugel
Caraco Pharmaceutical
Cardinal Health
Cardio3 BioSciences
Cardiokine
Cardiome Pharma
Cardium Therapeutics
CASiGEN Pharma
Catalent Pharma
Catalent Pharma Solutions
Catalyst Pharmaceutical
Cato Research
CCL Pharmaceuticals
CEL-SCI Corp
Celesio
Celgene
Cell Culture Service GmbH
Cell Targeting
Cell Therapeutics
Cell Therapeutics
Cell Therapy Catapult
Cellceutix
Celldex Therapeutics
Cellectar
Cellectis
Cellestis
CellTrion
Cellworks
Cellzome
Celsion
Celtic Pharma
Celtic Therapeutics
Cempra
Centella Therapeutics
Centocor
Centocor Ortho Biotech
Cephalon
Cepheid
Cequent Pharmaceuticals
Cerecor
Ceregene
Cerenis Therapeutics
CEVEC Pharmaceuticals
CGI Pharmaceuticals
Chai Therapeutics
Charles River Laboratories
CheilJedang
Chelsea Therapeutics
ChemGenex
Chemo Iberica
ChemoCentryx
ChemRar Hi-Tech
Chiasma
Chiesi Farmaceutici
Chimerix
China Biologic
China Health Resource
China Health System
China Medical System
China National Biotec
China Pharma Holdings
Chiome Bioscience
Chiron Behring
Chirotech
Chiva Pharma
Chroma Therapeutics
ChronTech Pharma
Chugai Pharmaceutical
Cilag GmbH
CIMA Labs
CIMAB
Cinpharm
Cinven
Cipher Pharmaceuticals
Cipla
Cipla Medpro
Clal Biotechnology
Clalit
Claris Lifesciences
Clavis Pharma
Cleveland BioLabs
Clinical Data
Clinigen Group
Clovis Oncology
CMC Biologics
CMIC
CNS Therapeutics
Cobrek Pharmaceuticals
CoCo Therapeutics
Cocrystal Discovery
CoDa Therapeutics
Codevax
Cognis
Coherus BioSciences
Coland
Colby Pharmaceutical
CollaGenex Pharmaceuticals
Colorcon
CoLucid
Columbia Laboratories
CombiMatrix
Complete Genomics
Compugen
Conatus Pharmaceuticals
Conba Pharmaceuticals
Conceptus
Concert Pharmaceuticals
Concordia Pharmaceuticals
ConfometRX
Conformetrix
Constellation Pharmaceuticals
ConvaTec
Convergence Pharmaceuticals
Corcept Therapeutics
CorImmun GmbH
Cornerstone Therapeutics
Coronado Biosciences
Cortecs plc
Cortex Pharmaceuticals
Cosme Farma
CoTherix
Covagen
Covance
Covella Pharma
Covidien
Covis Pharma
CP Pharmaceuticals
CPEX Pharmaceuticals
CPL Biologicals
CPL Biologics
Créapharm
Cristalia
Critical Pharmaceuticals
CritiTech
CROMA Pharma
Crucell
CSL Behring
CSL Biotherapies
CSL Limited
CSPC Pharmaceutical
Cubist Pharmaceuticals
CureDM
CureTech
CureVac
Curis
Cutanea Life Sciences
CVie Therapeutics
CVS Caremark
Cyclacel
Cyclacel Pharmaceuticals
CyDex Pharma
Cypress Bioscience
Cypress Pharmaceuticals
Cyprotex
Cytochroma
CytoDyn
Cytokine PharmaSciences
Cytokinetics
Cytomedix
Cytori Therapeutics
Cytos Biotechnology
CytRx
Hot Topics
Most Read
Boehringer Ingelheim gets FDA warning letter on cGMP failures
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Italy's pharma market slump set to continue, warns GlobalData
Is failure to adopt business process management putting the pharma industry at risk?
Boehringer Ingelheim gets FDA warning letter on cGMP failures
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
Italy's pharma market slump set to continue, warns GlobalData
Is failure to adopt business process management putting the pharma industry at risk?